17-7832924-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020877.5(DNAH2):​c.12974C>G​(p.Pro4325Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0316 in 1,614,136 control chromosomes in the GnomAD database, including 911 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 66 hom., cov: 32)
Exomes 𝑓: 0.032 ( 845 hom. )

Consequence

DNAH2
NM_020877.5 missense

Scores

6
5
6

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 6.60

Publications

17 publications found
Variant links:
Genes affected
DNAH2 (HGNC:2948): (dynein axonemal heavy chain 2) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. The axonemal dyneins, found in cilia and flagella, are components of the outer and inner dynein arms attached to the peripheral microtubule doublets. DNAH2 is an axonemal inner arm dynein heavy chain (Chapelin et al., 1997 [PubMed 9256245]).[supplied by OMIM, Mar 2008]
DNAH2 Gene-Disease associations (from GenCC):
  • spermatogenic failure 45
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008742511).
BP6
Variant 17-7832924-C-G is Benign according to our data. Variant chr17-7832924-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 402718.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0248 (3769/152264) while in subpopulation NFE AF = 0.0375 (2551/68012). AF 95% confidence interval is 0.0363. There are 66 homozygotes in GnomAd4. There are 1747 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 66 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH2NM_020877.5 linkc.12974C>G p.Pro4325Arg missense_variant Exon 84 of 86 ENST00000572933.6 NP_065928.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH2ENST00000572933.6 linkc.12974C>G p.Pro4325Arg missense_variant Exon 84 of 86 2 NM_020877.5 ENSP00000458355.1
DNAH2ENST00000389173.6 linkc.12974C>G p.Pro4325Arg missense_variant Exon 83 of 85 2 ENSP00000373825.2

Frequencies

GnomAD3 genomes
AF:
0.0248
AC:
3770
AN:
152146
Hom.:
67
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00705
Gnomad AMI
AF:
0.0417
Gnomad AMR
AF:
0.0244
Gnomad ASJ
AF:
0.0236
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0327
Gnomad FIN
AF:
0.0206
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0375
Gnomad OTH
AF:
0.0234
GnomAD2 exomes
AF:
0.0269
AC:
6760
AN:
251458
AF XY:
0.0288
show subpopulations
Gnomad AFR exome
AF:
0.00566
Gnomad AMR exome
AF:
0.0162
Gnomad ASJ exome
AF:
0.0245
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0228
Gnomad NFE exome
AF:
0.0365
Gnomad OTH exome
AF:
0.0276
GnomAD4 exome
AF:
0.0323
AC:
47225
AN:
1461872
Hom.:
845
Cov.:
32
AF XY:
0.0327
AC XY:
23792
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.00439
AC:
147
AN:
33478
American (AMR)
AF:
0.0169
AC:
756
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0268
AC:
700
AN:
26136
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.0337
AC:
2907
AN:
86258
European-Finnish (FIN)
AF:
0.0212
AC:
1131
AN:
53412
Middle Eastern (MID)
AF:
0.0251
AC:
145
AN:
5768
European-Non Finnish (NFE)
AF:
0.0356
AC:
39538
AN:
1112000
Other (OTH)
AF:
0.0314
AC:
1897
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
2896
5792
8689
11585
14481
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1442
2884
4326
5768
7210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0248
AC:
3769
AN:
152264
Hom.:
66
Cov.:
32
AF XY:
0.0235
AC XY:
1747
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00703
AC:
292
AN:
41548
American (AMR)
AF:
0.0243
AC:
372
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0236
AC:
82
AN:
3472
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5174
South Asian (SAS)
AF:
0.0329
AC:
159
AN:
4828
European-Finnish (FIN)
AF:
0.0206
AC:
218
AN:
10606
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0375
AC:
2551
AN:
68012
Other (OTH)
AF:
0.0237
AC:
50
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
202
404
606
808
1010
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0259
Hom.:
23
Bravo
AF:
0.0228
TwinsUK
AF:
0.0299
AC:
111
ALSPAC
AF:
0.0317
AC:
122
ESP6500AA
AF:
0.00726
AC:
32
ESP6500EA
AF:
0.0384
AC:
330
ExAC
AF:
0.0277
AC:
3357
Asia WGS
AF:
0.00953
AC:
33
AN:
3478
EpiCase
AF:
0.0393
EpiControl
AF:
0.0370

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

DNAH2-related disorder Benign:1
Oct 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.87
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.45
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
T;T
Eigen
Pathogenic
0.92
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.87
.;D
MetaRNN
Benign
0.0087
T;T
MetaSVM
Benign
-0.46
T
MutationAssessor
Pathogenic
4.5
H;H
PhyloP100
6.6
PrimateAI
Uncertain
0.74
T
PROVEAN
Pathogenic
-7.5
.;D
REVEL
Uncertain
0.31
Sift
Uncertain
0.0060
.;D
Polyphen
1.0
D;D
Vest4
0.47
MPC
0.97
ClinPred
0.057
T
GERP RS
4.5
Varity_R
0.83
gMVP
0.85
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116930996; hg19: chr17-7736242; COSMIC: COSV66717749; COSMIC: COSV66717749; API